About PHQ-9 and GAD-7
The Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) are the two most-used mental-health screening instruments in primary care worldwide. Together they detect ~85% of patients with depression or anxiety disorders. Both take ~5 minutes total, are validated across cultures and languages, and have well-defined severity cutoffs that map directly to treatment recommendations.
What a high score means — and doesn't mean
A high score doesn't mean you have a diagnosable mental illness. It means a clinician should take a closer look. Many things can produce elevated PHQ-9 / GAD-7 scores temporarily — recent grief, a stressful life event, thyroid dysfunction, sleep disorders, certain medications, inflammation, perimenopause. That's exactly why these scores are a starting point, not an endpoint.
PHQ-9 severity scoring
- 0–4: Minimal
- 5–9: Mild — watchful waiting; re-screen at 2 weeks
- 10–14: Moderate — consider therapy and/or medication
- 15–19: Moderately severe — active treatment recommended
- 20–27: Severe — immediate professional support
GAD-7 severity scoring
- 0–4: Minimal
- 5–9: Mild — sleep, exercise, grounding practices
- 10–14: Moderate — consider professional support (CBT is highly effective)
- 15+: Severe — strongly recommend professional support
Crisis resources (always free)
- United States: Suicide & Crisis Lifeline — call or text 988; chat at 988lifeline.org
- UK / Ireland: Samaritans — 116 123, free 24/7
- Australia: Lifeline — 13 11 14
- Canada: Talk Suicide Canada — 1-833-456-4566
- International: findahelpline.com — search by country
Your responses stay in your browser — nothing is sent to any server, no account is required, no data is logged.
References
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
- Spitzer RL et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-7.